AUTHOR=Tumurkhuu Gantsetseg , Chen Shuang , Montano Erica N. , Ercan Laguna Duygu , De Los Santos Gabriela , Yu Jeong Min , Lane Malcolm , Yamashita Michifumi , Markman Janet L. , Blanco Luz P. , Kaplan Mariana J. , Shimada Kenichi , Crother Timothy R. , Ishimori Mariko , Wallace Daniel J. , Jefferies Caroline A. , Arditi Moshe 

TITLE=Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-Induced Lupus Model

JOURNAL=Frontiers in Immunology

VOLUME=11

YEAR=2020

URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.554725

DOI=10.3389/fimmu.2020.554725

ISSN=1664-3224

ABSTRACT=<p>Systemic Lupus Erythematosus (SLE) is a chronic inflammatory autoimmune disease in which type I interferons (IFN) play a key role. The IFN response can be triggered when oxidized DNA engages the cytosolic DNA sensing platform cGAS-STING, but the repair mechanisms that modulate this process and govern disease progression are unclear. To gain insight into this biology, we interrogated the role of oxyguanine glycosylase 1 (OGG1), which repairs oxidized guanine 8-Oxo-2′-deoxyguanosine (8-OH-dG), in the pristane-induced mouse model of SLE. <italic>Ogg1</italic><sup>−/−</sup> mice showed increased influx of Ly6C<sup>hi</sup> monocytes into the peritoneal cavity and enhanced IFN-driven gene expression in response to short-term exposure to pristane. Loss of <italic>Ogg1</italic> was associated with increased auto-antibodies (anti-dsDNA and anti-RNP), higher total IgG, and expression of interferon stimulated genes (ISG) to longer exposure to pristane, accompanied by aggravated skin pathology such as hair loss, thicker epidermis, and increased deposition of IgG in skin lesions. Supporting a role for type I IFNs in this model, skin lesions of <italic>Ogg1</italic><sup>−/−</sup> mice had significantly higher expression of type I IFN genes (<italic>Isg15, Irf9</italic>, and <italic>Ifnb</italic>). In keeping with loss of <italic>Ogg1</italic> resulting in dysregulated IFN responses, enhanced basal and cGAMP-dependent <italic>Ifnb</italic> expression was observed in BMDMs from <italic>Ogg1</italic><sup>−/−</sup> mice. Use of the STING inhibitor, H151, reduced both basal and cGAMP-driven increases, indicating that OGG1 regulates <italic>Ifnb</italic> expression through the cGAS-STING pathway. Finally, in support for a role for OGG1 in the pathology of cutaneous disease, reduced <italic>OGG1</italic> expression in monocytes associated with skin involvement in SLE patients and the expression of <italic>OGG1</italic> was significantly lower in lesional skin compared with non-lesional skin in patients with Discoid Lupus. Taken together, these data support an important role for OGG1 in protecting against IFN production and SLE skin disease.</p>